MedPath

福建省泉州恒达制药有限公司

Ownership
-
Established
1990-02-26
Employees
-
Market Cap
-
Website
www.fjhdzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Ambroxol Hydrochloride Granules

Product Name
盐酸氨溴索颗粒
Approval Number
国药准字H20140100
Approval Date
Aug 14, 2024
NMPA

Ambroxol Hydrochloride Granules

Product Name
盐酸氨溴索颗粒
Approval Number
国药准字H20140099
Approval Date
Aug 14, 2024
NMPA

Nateglinide Capsules

Product Name
那格列奈胶囊
Approval Number
国药准字H20080430
Approval Date
May 4, 2023
NMPA

银黄胶囊

Approval Number
国药准字Z20063449
Approval Date
Jan 8, 2021
NMPA

穿心莲胶囊

Approval Number
国药准字Z20055315
Approval Date
Jan 8, 2021
NMPA

黄藤素片

Approval Number
国药准字Z20055323
Approval Date
Jan 8, 2021
NMPA

Sulfogaiaco,pentoxyverine and Promethazine Granules

Product Name
愈酚喷托异丙嗪颗粒
Approval Number
国药准字H35021207
Approval Date
Sep 16, 2020
NMPA

感冒退热颗粒

Approval Number
国药准字Z35020661
Approval Date
Sep 16, 2020
NMPA

复方满山白颗粒

Approval Number
国药准字Z20025797
Approval Date
Sep 16, 2020
NMPA

脉安颗粒

Approval Number
国药准字Z35020159
Approval Date
Sep 16, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.